Guardant Health, Inc. - Common Stock (GH) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2018 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
GH on Nasdaq
Shares outstanding
123,850,680
Price per share
$110.48
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
131,019,008
Total reported value
$13,380,992,393
% of total 13F portfolios
0.01%
Share change
+7,545,187
Value change
+$812,108,211
Number of holders
486
Price from insider filings
$110.48
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Guardant Health, Inc. - Common Stock (GH) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7.5% $460,074,314 9,288,801 BlackRock, Inc. 31 Mar 2025
Deep Track Capital, LP 4.4% $269,627,501 5,443,721 Deep Track Capital, LP 31 Mar 2025
CADIAN CAPITAL MANAGEMENT, LP 4.2% $258,624,114 5,221,565 Cadian Capital Management, LP 31 Dec 2024
WELLINGTON MANAGEMENT GROUP LLP 3.9% $240,233,923 4,850,271 Wellington Management Group LLP 31 Dec 2024

As of 31 Dec 2025, 486 institutional investors reported holding 131,019,008 shares of Guardant Health, Inc. - Common Stock (GH). This represents 106% of the company’s total 123,850,680 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Guardant Health, Inc. - Common Stock (GH) together control 69% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 9.8% 12,160,768 +2.1% 0.02% $1,242,100,844
BlackRock, Inc. 9.1% 11,317,714 -0.98% 0.02% $1,155,991,262
PRICE T ROWE ASSOCIATES INC /MD/ 4.6% 5,636,078 +34% 0.06% $575,670,000
Invesco Ltd. 4.3% 5,315,934 +7.8% 0.08% $542,969,482
BAILLIE GIFFORD & CO 3.9% 4,890,026 -4.6% 0.42% $499,467,256
Capital International Investors 2.8% 3,528,656 -25% 0.06% $360,416,924
FRANKLIN RESOURCES INC 2.7% 3,361,547 +15% 0.08% $343,348,455
GEODE CAPITAL MANAGEMENT, LLC 2.6% 3,213,657 +9.4% 0.02% $328,296,726
Deep Track Capital, LP 2.3% 2,800,000 -33% 6.5% $285,992,000
STATE STREET CORP 2.3% 2,795,727 +0.29% 0.01% $285,555,556
GOLDMAN SACHS GROUP INC 2.1% 2,627,573 +74% 0.04% $268,380,265
EVENTIDE ASSET MANAGEMENT, LLC 2% 2,511,091 -24% 4% $256,454,805
FULLER & THALER ASSET MANAGEMENT, INC. 2% 2,441,730 +3% 0.84% $249,398,349
FMR LLC 1.9% 2,396,433 +191% 0.01% $244,771,750
TWO SIGMA ADVISERS, LP 1.9% 2,382,300 +13% 0.47% $243,328,122
TWO SIGMA INVESTMENTS, LP 1.8% 2,171,903 +20% 0.33% $221,838,172
Driehaus Capital Management LLC 1.7% 2,143,193 -0.42% 1.5% $218,905,733
FEDERATED HERMES, INC. 1.6% 2,031,562 +14% 0.35% $207,503,743
LORD, ABBETT & CO. LLC 1.6% 1,988,983 +31% 0.62% $203,155,000
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 1.5% 1,915,581 -15% 0.04% $195,657,444
ALLIANCEBERNSTEIN L.P. 1.5% 1,901,308 +1263% 0.06% $194,199,599
UBS Group AG 1.4% 1,710,169 +17% 0.03% $174,676,662
Point72 Asset Management, L.P. 1.2% 1,499,169 +1364% 0.24% $153,125,122
RTW INVESTMENTS, LP 1.2% 1,481,033 0% 1.5% $151,272,711
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.2% 1,457,676 +3% 0.02% $148,887,039

Institutional Holders of Guardant Health, Inc. - Common Stock (GH) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 131,019,008 $13,380,992,393 +$812,108,211 $102.14 486
2025 Q3 122,497,007 $7,653,274,239 -$62,636,623 $62.48 389
2025 Q2 124,295,969 $6,467,826,507 +$330,760,770 $52.04 359
2025 Q1 118,497,703 $5,048,168,027 +$16,046,986 $42.60 336
2024 Q4 119,495,658 $3,649,677,643 -$152,886,448 $30.55 294
2024 Q3 124,539,664 $2,855,453,478 +$192,800,636 $22.94 264
2024 Q2 114,848,348 $3,316,872,682 +$179,592,491 $28.88 274
2024 Q1 111,383,571 $2,296,334,142 -$29,707,645 $20.63 252
2023 Q4 110,309,454 $2,983,894,470 +$45,961,733 $27.05 289
2023 Q3 108,297,993 $3,210,080,906 -$83,646,730 $29.64 289
2023 Q2 110,144,879 $3,943,258,288 +$694,610,966 $35.80 293
2023 Q1 92,579,337 $2,168,850,990 -$17,004,713 $23.44 271
2022 Q4 94,289,245 $2,564,763,814 -$199,503,944 $27.20 280
2022 Q3 94,962,606 $5,108,852,818 +$162,272,236 $53.83 310
2022 Q2 92,768,225 $3,745,003,930 -$39,996,274 $40.34 310
2022 Q1 92,443,619 $6,110,748,734 -$81,915,249 $66.24 335
2021 Q4 92,085,897 $9,209,883,362 -$251,467,115 $100.02 379
2021 Q3 94,130,065 $11,765,302,482 +$583,304,963 $125.01 365
2021 Q2 89,577,134 $11,124,047,648 -$275,498,694 $124.19 410
2021 Q1 91,351,911 $13,941,648,366 +$681,296,473 $152.65 410
2020 Q4 87,374,557 $11,260,127,731 +$219,249,861 $128.88 399
2020 Q3 85,443,260 $9,550,543,816 +$176,117,596 $111.78 341
2020 Q2 84,323,375 $6,840,933,865 +$491,051,528 $81.13 311
2020 Q1 78,329,707 $5,451,350,483 +$31,071,063 $69.60 281
2019 Q4 77,055,101 $6,021,065,515 +$259,064,552 $78.14 261
2019 Q3 73,811,798 $4,711,407,821 -$154,907,012 $63.83 230
2019 Q2 75,988,996 $6,559,989,770 +$1,412,721,312 $86.33 214
2019 Q1 60,292,447 $4,622,332,723 +$11,801,888 $76.70 144
2018 Q4 61,703,860 $2,318,551,779 +$2,050,102,770 $37.59 87